Paragon 28 Launches PRECISION Jones Fracture Screw
Paragon 28 launched the PRECISIONâ„¢ Jones Fracture Screw system. May 30, 2017
Amedica Announces Delayed Filing of Form 10-Q, Receipt of Nasdaq Letter
Amedica delayed the filing of its Quarterly Report on Form 10-Q for 1Q17, and received a listing non-compliance notice from NASDAQ. May 30, 2017
VEXIM Receives ANVISA Approval for SpineJack Implants
VEXIM received regulatory approval from ANVISA to commercialize SpineJack® in Brazil. May 30, 2017
Bodycad Permitted to Launch Personalized Knee System in EU
Bodycad received product notification confirmation which enables them to commercially launch their Unicompartmental Knee System within the European Union. May 25, 2017
SurGenTec Receives US Patent for GRAFTGUN
SurGenTec was granted U.S. Patent No. 9,655,748, Bone Graft Delivery System and Method for Using Same, pertaining to the GRAFTGUN® device. May 25, 2017
Anika Enrolls First Patient in Supplemental Phase III CINGAL Trial
Anika Therapeutics enrolled the first patient in a supplemental Phase III trial evaluating CINGAL® viscosupplement for the treatment of knee OA symptoms. May 25, 2017
LITHOMED to Distribute SANUWAVE Orthopaedic Products in Taiwan
SANUWAVE Health appointed LITHOMED to distribute the orthoPACE® shockwave therapy device in Taiwan. May 25, 2017
NovaBone Adds New Biologically-active Bone Graft Substitutes
NovaBone Products launched NovaBone IRM and NovaBone IRM MacroPOR to its portfolio of biologically-active bone graft substitutes. May 24, 2017
First Surgery Completed with Gramercy Extremity Orthopedic Systems
Gramercy Extremity Orthopedics announced completion of the first surgery using its GEO™ Bone Screw and GEO CART™ systems. May 24, 2017
CINGAL Phase III Data Demonstrates Efficacy and Safety to Treat Knee OA Pain
Phase III study results demonstrated that Anika Therapeutics’ CINGAL® provided superior immediate and short term OA pain relief after injection vs. hyaluronic acid alone, and superior relief at 26 weeks vs. saline. May 23, 2017
